chr6-129438641-C-T

Variant summary

Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBP6_Very_Strong

The NM_000426.4(LAMA2):​c.5969-5C>T variant causes a splice region, intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000303 in 1,466,316 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 3/3 splice prediction tools predict no significant impact on normal splicing. Variant has been reported in ClinVar as Likely benign (★★).

Frequency

Genomes: 𝑓 0.00054 ( 0 hom., cov: 32)
Exomes 𝑓: 0.00028 ( 0 hom. )

Consequence

LAMA2
NM_000426.4 splice_region, intron

Scores

2
Splicing: ADA: 0.00008116
2

Clinical Significance

Likely benign criteria provided, multiple submitters, no conflicts B:4

Conservation

PhyloP100: 0.467

Publications

0 publications found
Variant links:
Genes affected
LAMA2 (HGNC:6482): (laminin subunit alpha 2) Laminin, an extracellular protein, is a major component of the basement membrane. It is thought to mediate the attachment, migration, and organization of cells into tissues during embryonic development by interacting with other extracellular matrix components. It is composed of three subunits, alpha, beta, and gamma, which are bound to each other by disulfide bonds into a cross-shaped molecule. This gene encodes the alpha 2 chain, which constitutes one of the subunits of laminin 2 (merosin) and laminin 4 (s-merosin). Mutations in this gene have been identified as the cause of congenital merosin-deficient muscular dystrophy. Two transcript variants encoding different proteins have been found for this gene. [provided by RefSeq, Jul 2008]
LAMA2 Gene-Disease associations (from GenCC):
  • congenital merosin-deficient muscular dystrophy 1A
    Inheritance: AR Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Orphanet, Labcorp Genetics (formerly Invitae), Myriad Women’s Health, G2P
  • LAMA2-related muscular dystrophy
    Inheritance: AR Classification: DEFINITIVE Submitted by: ClinGen
  • muscular dystrophy, limb-girdle, autosomal recessive 23
    Inheritance: AR Classification: STRONG Submitted by: Labcorp Genetics (formerly Invitae)

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -12 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.6).
BP6
Variant 6-129438641-C-T is Benign according to our data. Variant chr6-129438641-C-T is described in ClinVar as Likely_benign. ClinVar VariationId is 543882.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
LAMA2NM_000426.4 linkc.5969-5C>T splice_region_variant, intron_variant Intron 41 of 64 ENST00000421865.3 NP_000417.3
LAMA2NM_001079823.2 linkc.5969-5C>T splice_region_variant, intron_variant Intron 41 of 63 NP_001073291.2

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
LAMA2ENST00000421865.3 linkc.5969-5C>T splice_region_variant, intron_variant Intron 41 of 64 5 NM_000426.4 ENSP00000400365.2 P24043
LAMA2ENST00000618192.5 linkc.6233-5C>T splice_region_variant, intron_variant Intron 42 of 65 5 ENSP00000480802.2 A0A087WX80
LAMA2ENST00000617695.5 linkc.5969-5C>T splice_region_variant, intron_variant Intron 41 of 63 5 ENSP00000481744.2 A0A087WYF1

Frequencies

GnomAD3 genomes
AF:
0.000536
AC:
81
AN:
151192
Hom.:
0
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.00131
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.000857
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.000193
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.000192
Gnomad OTH
AF:
0.00
GnomAD2 exomes
AF:
0.000237
AC:
59
AN:
249358
AF XY:
0.000200
show subpopulations
Gnomad AFR exome
AF:
0.00106
Gnomad AMR exome
AF:
0.000145
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.0000545
Gnomad FIN exome
AF:
0.000186
Gnomad NFE exome
AF:
0.000258
Gnomad OTH exome
AF:
0.000330
GnomAD4 exome
AF:
0.000276
AC:
363
AN:
1315008
Hom.:
0
Cov.:
19
AF XY:
0.000272
AC XY:
180
AN XY:
662336
show subpopulations
African (AFR)
AF:
0.00137
AC:
42
AN:
30576
American (AMR)
AF:
0.000135
AC:
6
AN:
44368
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
25116
East Asian (EAS)
AF:
0.0000772
AC:
3
AN:
38856
South Asian (SAS)
AF:
0.0000241
AC:
2
AN:
83156
European-Finnish (FIN)
AF:
0.000169
AC:
9
AN:
53110
Middle Eastern (MID)
AF:
0.000182
AC:
1
AN:
5480
European-Non Finnish (NFE)
AF:
0.000291
AC:
285
AN:
978932
Other (OTH)
AF:
0.000271
AC:
15
AN:
55414
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.497
Heterozygous variant carriers
0
20
41
61
82
102
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Variant carriers
0
20
40
60
80
100
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.000535
AC:
81
AN:
151308
Hom.:
0
Cov.:
32
AF XY:
0.000663
AC XY:
49
AN XY:
73898
show subpopulations
African (AFR)
AF:
0.00131
AC:
54
AN:
41324
American (AMR)
AF:
0.000856
AC:
13
AN:
15182
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
3462
East Asian (EAS)
AF:
0.000193
AC:
1
AN:
5168
South Asian (SAS)
AF:
0.00
AC:
0
AN:
4792
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
10362
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
294
European-Non Finnish (NFE)
AF:
0.000192
AC:
13
AN:
67716
Other (OTH)
AF:
0.00
AC:
0
AN:
2096
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.482
Heterozygous variant carriers
0
5
10
14
19
24
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.000335
Hom.:
0
Bravo
AF:
0.000540
Asia WGS
AF:
0.00433
AC:
15
AN:
3478
EpiCase
AF:
0.000273
EpiControl
AF:
0.000237

ClinVar

Significance: Likely benign
Submissions summary: Benign:4
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:3
Mar 04, 2021
GeneDx
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

-
Diagnostic Laboratory, Department of Genetics, University Medical Center Groningen
Significance:Likely benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

-
Joint Genome Diagnostic Labs from Nijmegen and Maastricht, Radboudumc and MUMC+
Significance:Likely benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

LAMA2-related muscular dystrophy Benign:1
Oct 30, 2024
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.60
CADD
Benign
5.4
DANN
Benign
0.60
PhyloP100
0.47

Splicing

Name
Calibrated prediction
Score
Prediction
dbscSNV1_ADA
Benign
0.000081
dbscSNV1_RF
Benign
0.0040
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs201853235; hg19: chr6-129759786; COSMIC: COSV70338346; COSMIC: COSV70338346; API